Lactoferrin-Functionalized CuS Nanoparticles for NIR-II Photoacoutic Imaging-Guided Photothermal Tumor Ablation with ROS Scavenging and Inflammation Alleviating Effects
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Lan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi 030001, China. Hauptthemen laut MEDLINE: Lactoferrin, Copper, Photothermal Therapy, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science and Technology Innovation Group of Shanxi Province, Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Shanxi Province Higher Education Billion Project Science and Technology Guid-ance Project.
Abstract (Originalsprache)
Photothermal therapy (PTT) in the near-infrared II window (NIR-II, 1000-1700 nm) is favored for noninvasive cancer treatment due to its deep tissue penetration, reduced background interference, and better biosecurity. However, excessive reactive oxygen species (ROS) and inflammatory cytokines during localized hyperthermia limit its therapeutic efficiency. In this work, lactoferrin-functionalized copper sulfide nanoparticles (Lf-CuS NPs) with a hydrodynamic size of 31.2 nm were synthesized via "one-step" biomineralization for NIR-II-guided photothermal therapy. The Lf-CuS NPs exhibited efficient NIR-II light absorption at 1064 nm, high photostability for effective PTT, and desirable ROS scavenging capability for inflammation-resolving therapy. Following a 1064 nm laser irradiation of 1.0 W/cm2, 4T1 tumors were efficiently ablated with no recurrence over a 14 day period. Remarkably, Lf-CuS NPs possessed good photoacoustic imaging (PAI) capabilities, enabling real-time monitoring of their accumulation at the target site after intravenous administration. This ensures precise timing for PTT, optimizing therapeutic outcomes while reducing potential damage to the surrounding skin and tissues. Furthermore, the low toxicity of Lf-CuS NPs was confirmed through extensive in vitro and in vivo experiments, highlighting their potential as a promising photothermal agent. In conclusion, this research presents a promising strategy for tumor-targeted therapy and highlights lactoferrin as an inflammation alleviating agent in antitumor application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.
- Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China.
- The Radiology Department of Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Bo Fan, Ruiping Zhang
Förderung
- Science and Technology Innovation Group of Shanxi Province
- Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University
- Shanxi Province Higher Education Billion Project Science and Technology Guid-ance Project
- Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province
- Fundamental Research Program of Shanxi Province
Zitieren
APA
Liu, L., Wu, Q., Rong, S., Zhang, J., Wang, N., Xing, Y., Fan, B., & Zhang, R. (2026). Lactoferrin-Functionalized CuS Nanoparticles for NIR-II Photoacoutic Imaging-Guided Photothermal Tumor Ablation with ROS Scavenging and Inflammation Alleviating Effects. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01418
Vancouver
Liu L, Wu Q, Rong S, Zhang J, Wang N, Xing Y, et al. Lactoferrin-Functionalized CuS Nanoparticles for NIR-II Photoacoutic Imaging-Guided Photothermal Tumor Ablation with ROS Scavenging and Inflammation Alleviating Effects. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01418
BibTeX
@article{Liu2026,
author = {Liu, Lan and Wu, Qian and Rong, Shuo and Zhang, Juan and Wang, Na and Xing, Yang and Fan, Bo and Zhang, Ruiping},
title = {Lactoferrin-Functionalized CuS Nanoparticles for NIR-II Photoacoutic Imaging-Guided Photothermal Tumor Ablation with ROS Scavenging and Inflammation Alleviating Effects},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01418}
}
EUVIMED